These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
168 related articles for article (PubMed ID: 9141203)
1. Booster immunization of low- and non-responders after a standard three dose hepatitis B vaccine schedule--results of a post-marketing surveillance. Clemens R; Sänger R; Kruppenbacher J; Höbel W; Stanbury W; Bock HL; Jilg W Vaccine; 1997 Mar; 15(4):349-52. PubMed ID: 9141203 [TBL] [Abstract][Full Text] [Related]
2. Intradermal vaccination of adults with three low doses (2 micrograms) of recombinant hepatitis B vaccine. II. Persistence of immunity and induction of immunologic memory. Elisbão Mdo C; Baldy JL; Bonametti AM; Reiche EM; Morimoto HK; Pontello R; Matsuo T; Ferelle A; Neves J Mem Inst Oswaldo Cruz; 2003 Dec; 98(8):1109-13. PubMed ID: 15049099 [TBL] [Abstract][Full Text] [Related]
3. Immunogenicity and reactogenicity of a recombinant hepatitis B vaccine in subjects over age of forty years and response of a booster dose among nonresponders. Das K; Gupta RK; Kumar V; Kar P World J Gastroenterol; 2003 May; 9(5):1132-4. PubMed ID: 12717874 [TBL] [Abstract][Full Text] [Related]
4. Comparative long term immunogenicity of two recombinant hepatitis B vaccines and the effect of a booster dose given after five years in a low endemicity country. Duval B; Gîlca V; Boulianne N; De Wals P; Massé R; Trudeau G; De Serres G Pediatr Infect Dis J; 2005 Mar; 24(3):213-8. PubMed ID: 15750456 [TBL] [Abstract][Full Text] [Related]
5. Hepatitis B vaccine booster dose: low-dose recombinant hepatitis B vaccines as a booster dose. Bryan JP; MacArthy P; Rudock A; Fogarty JP; Dowd H; Legters LJ; Perine PL Am J Infect Control; 1997 Jun; 25(3):215-22. PubMed ID: 9202817 [TBL] [Abstract][Full Text] [Related]
6. Long-term persistence in protection and response to a hepatitis B vaccine booster among adolescents immunized in infancy in the western region of China. Wang ZZ; Gao YH; Lu W; Jin CD; Zeng Y; Yan L; Ding F; Li T; Liu XE; Zhuang H Hum Vaccin Immunother; 2017 Apr; 13(4):909-915. PubMed ID: 27874311 [TBL] [Abstract][Full Text] [Related]
7. Antibody and immune memory persistence after vaccination of preadolescents with low doses of recombinant hepatitis B vaccine. Gilca V; De Serres G; Boulianne N; De Wals P; Murphy D; Trudeau G; Deceuninck G; Massé R; Duval B Hum Vaccin; 2010 Feb; 6(2):212-8. PubMed ID: 19946212 [TBL] [Abstract][Full Text] [Related]
8. Persistence of protection against hepatitis B virus infection among adolescents vaccinated with recombinant hepatitis B vaccine beginning at birth: a 15-year follow-up study. Bialek SR; Bower WA; Novak R; Helgenberger L; Auerbach SB; Williams IT; Bell BP Pediatr Infect Dis J; 2008 Oct; 27(10):881-5. PubMed ID: 18756185 [TBL] [Abstract][Full Text] [Related]
9. Evaluation of the response to a booster dose of hepatitis B vaccine in previously immunized healthcare workers. Williams JL; Christensen CJ; McMahon BJ; Bulkow LR; Cagle HH; Mayers JS; Zanis CL; Parkinson AJ; Margolis HS Vaccine; 2001 Jul; 19(28-29):4081-5. PubMed ID: 11427285 [TBL] [Abstract][Full Text] [Related]
10. Acquisition rate of antibody to hepatitis B surface antigen among medical and dental students in Japan after three-dose hepatitis B vaccination. Nagashima S; Yamamoto C; Ko K; Chuon C; Sugiyama A; Ohisa M; Akita T; Katayama K; Yoshihara M; Tanaka J Vaccine; 2019 Jan; 37(1):145-151. PubMed ID: 30449632 [TBL] [Abstract][Full Text] [Related]
11. Antibody response to revaccination among adult non-responders to primary Hepatitis B vaccination in China. Zhang L; Liu J; Lu J; Yan B; Song L; Li L; Cui F; Zhang G; Wang F; Liang X; Xu A Hum Vaccin Immunother; 2015; 11(11):2716-22. PubMed ID: 26252481 [TBL] [Abstract][Full Text] [Related]
12. Randomized, comparative trial of 20 micrograms vs 40 micrograms Engerix B vaccine in hepatitis B vaccine non-responders. Goldwater PN Vaccine; 1997 Mar; 15(4):353-6. PubMed ID: 9141204 [TBL] [Abstract][Full Text] [Related]
13. Differences in response to a hepatitis B vaccine booster dose among Alaskan children and adolescents vaccinated during infancy. Samandari T; Fiore AE; Negus S; Williams JL; Kuhnert W; McMahon BJ; Bell BP Pediatrics; 2007 Aug; 120(2):e373-81. PubMed ID: 17636112 [TBL] [Abstract][Full Text] [Related]
14. Response to an extra dose of hepatitis B vaccine and specific antibody persistence in non-responders to primary immunization. Chiaramonte M; Ngatchu T; Majori S; Baldo V; Moschen ME; Renzulli G; Trivello R Scand J Gastroenterol; 1995 Jun; 30(6):601-3. PubMed ID: 7569770 [TBL] [Abstract][Full Text] [Related]
15. Implementation of hepatitis B vaccine in high-risk young adults with waning immunity. Posuwan N; Vorayingyong A; Jaroonvanichkul V; Wasitthankasem R; Wanlapakorn N; Vongpunsawad S; Poovorawan Y PLoS One; 2018; 13(8):e0202637. PubMed ID: 30125298 [TBL] [Abstract][Full Text] [Related]
16. Response to a booster dose 18 months after a low anti-HBs response (10-99 IU/l) to three doses of intradermally or intramuscularly administered recombinant hepatitis B vaccine. Struve J; Aronsson B; Frenning B; Forsgren M; Weiland O Infection; 1995; 23(1):42-5. PubMed ID: 7744490 [TBL] [Abstract][Full Text] [Related]
17. Immune response to hepatitis B vaccine with high antigen content in non-responders after standard primary vaccination in Chinese adults. Pan HX; Zeng Y; Song XF; Zhang YJ; Xu K; Liang ZL; Zhu FC Vaccine; 2014 Jun; 32(29):3706-12. PubMed ID: 24681228 [TBL] [Abstract][Full Text] [Related]
18. Low dose revaccination induces robust protective anti-HBs antibody response in the majority of healthy non-responder neonates. Jafarzadeh A; Zarei S; Shokri F Vaccine; 2008 Jan; 26(2):269-76. PubMed ID: 18037544 [TBL] [Abstract][Full Text] [Related]
19. Revaccination of non- and low- responders after a standard three dose hepatitis B vaccine schedule. Han K; Shao X; Zheng H; Wu C; Zhu J; Zheng X; Zhang Y Hum Vaccin Immunother; 2012 Dec; 8(12):1845-9. PubMed ID: 22906933 [TBL] [Abstract][Full Text] [Related]
20. Hepatitis B immune memory in children primed with hexavalent vaccines and given monovalent booster vaccines: an open-label, randomised, controlled, multicentre study. Zanetti AR; Romanò L; Giambi C; Pavan A; Carnelli V; Baitelli G; Malchiodi G; Valerio E; Barale A; Marchisio MA; Montù D; Tozzi AE; D'Ancona F; Lancet Infect Dis; 2010 Nov; 10(11):755-61. PubMed ID: 20884297 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]